Davide Quaresmini
Overview
Explore the profile of Davide Quaresmini including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
451
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tommasi S, Maurmo L, Rizzo A, Carella C, Ranieri G, De Summa S, et al.
Front Med (Lausanne)
. 2024 Nov;
11:1511339.
PMID: 39526241
[This corrects the article DOI: 10.3389/fmed.2024.1432628.].
2.
Tommasi S, Maurmo L, Rizzo A, Carella C, Ranieri G, De Summa S, et al.
Front Med (Lausanne)
. 2024 Sep;
11:1432628.
PMID: 39323465
Introduction: The management of cancer patients follows a Diagnostic Therapeutic and Care Pathway (PDTA) approach, aimed at achieving the optimal balance between care and quality of life. To support this...
3.
Vitale E, Rizzo A, Maistrello L, Nardulli P, Talienti T, Quaresmini D, et al.
Front Oncol
. 2024 Aug;
14:1409132.
PMID: 39091909
Background: We performed a systematic review and meta-analysis to further explore the impact of the addition of immunotherapy to gemcitabine-cisplatin as first-line treatment for advanced biliary tract cancer (BTC) patients....
4.
Sapuppo E, Brunetti O, Tessitore D, Brandi G, Di Giovanni N, Fadda G, et al.
Crit Rev Oncol Hematol
. 2022 Dec;
181:103892.
PMID: 36481306
Adenocarcinoma represents the most frequent biliary tract cancer. However, other rare histotypes can be found in the biliary tract, such as cholangiolocellular carcinoma, cholangiocarcinoma with ductal plate malformation pattern, adenosquamous...
5.
Massafra R, Bove S, La Forgia D, Comes M, Didonna V, Gatta G, et al.
Cancers (Basel)
. 2022 May;
14(9).
PMID: 35565344
Characterization of breast cancer into intrinsic molecular profiles has allowed women to live longer, undergoing personalized treatments. With the aim of investigating the relation between different values of ki67 and...
6.
Guida M, Bartolomeo N, Quaresmini D, Quaglino P, Madonna G, Pigozzo J, et al.
J Transl Med
. 2022 Apr;
20(1):159.
PMID: 35382857
Background: To evaluate the capability of basal and one-month differed white blood cells (WBC), neutrophil, lymphocyte and platelet values and their ratios (neutrophils-to-lymphocytes ratio, NLR, and platelets-to-lymphocytes ratio, PLR) in...
7.
Strippoli S, Fanizzi A, Quaresmini D, Nardone A, Armenio A, Figliuolo F, et al.
Front Oncol
. 2021 Nov;
11:686308.
PMID: 34820323
Background: Cutaneous squamous cell carcinoma (CSCC) is the second most common skin cancer whose incidence is growing parallel to the lengthening of the average lifespan. Cemiplimab, an antiPD-1 monoclonal antibody,...
8.
Quaresmini D, Di Lauro A, Fucci L, Strippoli S, De Risi I, Sciacovelli A, et al.
Front Oncol
. 2021 Oct;
11:742666.
PMID: 34604086
Background: Immunotherapy with immune checkpoint inhibitors is one of the main therapies for advanced melanoma. Nevertheless, albeit remarkable, immunotherapy results are still unsatisfactory as more than half of patients progress,...
9.
Buquicchio R, Mastrandrea V, Strippoli S, Quaresmini D, Guida M, Filotico R
Front Oncol
. 2021 Sep;
11:691980.
PMID: 34540666
Background: Pemphigus vulgaris (PV) is a rare and severe autoimmune blistering disorder affecting the skin and mucous membranes, characterized by the production of autoantibodies against two desmosomal adhesion proteins, desmoglein...
10.
Strippoli S, Fanizzi A, Negri A, Quaresmini D, Nardone A, Armenio A, et al.
Cells
. 2021 Mar;
10(2).
PMID: 33669266
Background: The role of circulating CD4/CD8 double-negative T cells (DNTs) in the immune response to melanoma is poorly understood, as are the effects of checkpoint inhibitors on T cell subpopulations....